Hospital
Baptist Memorial Hospital-Tipton
Baptist Memorial Hospital-Tipton was paid $13.88M by Medicaid between Jan 2018 and Dec 2024, across 113 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoBAPTIST MEMORIAL HOSPITAL-TIPTON
COVINGTON, TN 38019
COVINGTON, TN 38019
33aNPI1316901937assigned 04/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.88M
24GClaims523,646
24DCodes billed113
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#21 of 71
Median peer was paid$6.96M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,937 | $2.04M | |
| 2019 | 52,567 | $1.62M | |
| 2020 | 73,984 | $1.60M | |
| 2021 | 100,080 | $2.25M | |
| 2022 | 98,292 | $2.38M | |
| 2023 | 93,840 | $2.30M | |
| 2024incomplete | 57,946 | $1.68M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 22,444 | 19,299 | $3.47M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 13,257 | 10,730 | $2.69M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 22,216 | 20,073 | $2.41M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.7% | 6,300 | 3,007 | $511K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.3% | 11,645 | 9,534 | $459K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 5,865 | 5,355 | $369K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 67,702 | 44,812 | $360K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.3% | 16,077 | 11,541 | $325K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.0% | 14,629 | 9,898 | $277K |
| 80053 | Comprehensive metabolic panel | 1.7% | 62,041 | 41,707 | $232K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 5,188 | 4,460 | $180K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 4,174 | 3,774 | $180K |
101 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 23,251 | $178K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 9,193 | $173K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 3,241 | $163K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 2,276 | $145K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,067 | $125K |
| G0378 | Hospital observation service, per hour | <1% | 1,188 | $113K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 9,507 | $110K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 11,451 | $107K |
| 84484 | <1% | 7,936 | $106K | |
| 71045 | Radiologic examination, chest; single view | <1% | 9,041 | $105K |
| 36415 | Collection of venous blood by venipuncture | <1% | 57,667 | $92K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,400 | $85K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,449 | $73K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,658 | $71K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,049 | $69K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,965 | $67K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 46 | $62K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,542 | $54K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 315 | $52K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 888 | $50K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,157 | $48K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 3,126 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,734 | $34K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,521 | $32K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 889 | $27K |
| 83735 | <1% | 6,151 | $27K | |
| 81025 | <1% | 6,422 | $26K | |
| 81003 | <1% | 22,638 | $21K | |
| 83690 | <1% | 2,814 | $16K | |
| 82728 | <1% | 5,391 | $15K | |
| 87807 | <1% | 1,272 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,843 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 198 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 156 | $11K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 145 | $11K |
| 83550 | <1% | 5,142 | $10K | |
| 83540 | <1% | 5,149 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 26 | $7K |
| 83605 | <1% | 808 | $5K | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 476 | $4K |
| 82607 | <1% | 2,352 | $4K | |
| 83880 | <1% | 312 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 794 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,867 | $3K |
| 82746 | <1% | 2,356 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 324 | $3K |
| 96367 | <1% | 130 | $2K | |
| 85027 | <1% | 494 | $2K | |
| 87040 | <1% | 201 | $2K | |
| 83615 | <1% | 3,098 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 30 | $2K |
| 96417 | <1% | 35 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,328 | $1K |
| 84703 | <1% | 155 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 120 | $1K |
| 85379 | <1% | 106 | $962.71 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 841 | $955.16 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 107 | $819.85 |
| 0031A | <1% | 19 | $704.00 | |
| 96376 | <1% | 72 | $678.55 | |
| 84100 | <1% | 1,136 | $666.96 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 24 | $600.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 33 | $575.07 |
| 84702 | <1% | 16 | $372.19 | |
| 82150 | <1% | 66 | $297.44 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 606 | $256.17 |
| 84132 | <1% | 19 | $224.98 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 45 | $185.04 |
| 36416 | <1% | 106 | $140.00 | |
| 82378 | <1% | 110 | $115.93 | |
| 86300 | <1% | 160 | $112.02 | |
| 99442 | <1% | 17 | $106.91 | |
| 85652 | <1% | 72 | $95.66 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 134 | $91.39 |
| 80061 | Lipid panel | <1% | 28 | $90.23 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 210 | $85.86 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 102 | $85.05 |
| 73610 | <1% | 13 | $82.77 | |
| 87210 | <1% | 19 | $71.29 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 30 | $60.91 |
| 86140 | <1% | 71 | $59.56 | |
| 81001 | <1% | 44 | $52.00 | |
| 85610 | <1% | 34 | $41.73 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,427 | $21.42 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 145 | $20.14 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 25 | $2.16 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,525 | $1.85 |
| 91303 | <1% | 19 | $0.03 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 777 | $0.02 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 17 | $0.00 |
| A9270 | Non-covered item or service | 0% | 3,455 | $0.00 |
| 84238 | 0% | 100 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 274 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 96 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 85 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 22 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 3,217 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 823 | $0.00 |
| 85045 | 0% | 44 | $0.00 | |
| 84439 | 0% | 17 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUCKETT, GREGORY (SR VP/ CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.